Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

Thomas Gibson is the co-founder and chief executive officer at MedGlobal Group, a multisided marketplace for the medical industry. After spending 22 years as an executive for healthcare and hospital organizations, Thomas founded MedGlobal Group with his wife, Patricia, recognizing the need to use technology to help solve the challenges of making healthcare equipment, products, and services accessible to the world. Their international platforms combine technology and tools to help connect manufacturers and distributors with global buyers. Thomas and Patricia believe healthcare is more than a business, and we have a responsibility to ensure medical equipment and products are made available to all parts of the world. Our platforms provide sourcing opportunities for both new and used medical products, and we publish a fully-interactive digital magazine focused on the industry. Thomas holds dual BAs in Business Administration and Emergency Management. Thomas received the American Society of Healthcare Engineering Emerging Leader of the Year Award and is the past president of the Florida Healthcare Engineering Association. Thomas and Patricia also operate the Gibson Soto foundation, a nonprofit that helps young women rise from poverty through education.

Nicholas Focil is the CEO at Fomat Medical Research, a network of research centers based in Oxnard, California. Nicholas graduated from California with a Biochemistry and MBA degree. During his undergrad days, he spent his extra time in a research lab working with a nominated noble laureate performing investigator-initiated studies, and publishing weekly articles for a spectrum of publications. Was then recruited by Medtronic MiniMed Diabetes division to do pre-pivotal trials. Thereafter, was recruited for the purpose of managing and expanding Diverse Research Solutions. He then spearheaded the spinoff and expansion of FOMAT Medical Research through both the U.S. and Latin America with current operations in the USA (California and Florida), Ecuador, Colombia, and Peru. With well over a decade of research experience, Nicholas, as the CEO of Fomat Medical Research and proud founding partner of hyper core International, continues to innovate and pioneer clinical research in both regions.

Jim Ohneck is the Founder and Chief Executive Officer (CEO) of Epoch Lasers and holds a US patent for his unique Laser Therapy device for treating chronic pain. Jim holds degrees in Business Administration and Electronic Engineering and has thirty-five years of medical device development experience. He is a Fellow of the American Society of Laser Medicine & Surgery (ASLMS), a Member of the International Society of Optics and Photonics and of the International Microelectronic Packaging Association, and an Adjunct Faculty at Notre Dame College in Cleveland, OH where he teaches International Finance and Marketing.

Luís Meireles is currently CEO and co-owner of MDI Industrial a Medical Device Industry in Brazil and a senior consultant for European companies. Luís is Portuguese, Ph.D. in Biotechnology but moved to Brazil, spending the last decade helping to introduce medical devices into Latin America he was responsible for the introduction of Mortara Instruments in Brazil with a successful plan growing from almost zero to one of the market leaders. He was a senior consultant for Hill-Rom visiting almost all countries in Latin America, being perfectly aware of the difficulties of implementing and growing the health market in LATAM, especially in Brazil.

Christian is an entrepreneur and advisor in the bio, pharma, healthcare, and technology sectors with 20 years of strategic advisory, business creation, development, and operational experience. He works with biotech companies and VCs on business development and strategy, with industry on innovation, pipeline, and business development, with institutions on technology transfer & innovation, with governments, institutions, and systems on innovation strategy, policy, and ecosystem development, and has served on biotech, patient organization, and non-profit boards.
He led a turn-around of Europe’s largest biotech association which he represented among the BIO "Heads of Associations" group, was the lead advisor, dialogue moderator, and “rapporteur” for the European Commission’s 3-year strategic “Innovation in Healthcare” initiative to revise innovation funding policy based on stakeholder input from industry executives, VCs, biotech CEOs, and technology transfer directors, and has worked with SMEs, industry, and governments in Europe, North America, and Latin America. Christian coordinated the first European level entrepreneur training Bootcamp for biotech founders/CEOs, built the first European biotech investment initiative in collaboration with the EC and EASDAQ (now Euronext), industry and investors, and has extensive experience coaching & mentoring entrepreneurs, CEOs, and tech transfer directors.

Mona Oliveira is one of the creators and founders of the startup BIOLINKER, which in 2019 was awarded as one of the TOP 500 best startups in the world in the area of biotechnology for the project she coordinates. Double Ph.D. in Biochemistry and Nanotechnology from USP (Brazil) and IJS (Slovenia). During her academic career, she has accumulated awards and honors for performance and scientific excellence, publishing in annals and journals of international renown. Currently, he is Co-CEO of BIOLINKER acting in scientific operations and negotiations. After three years of foundation, BIOLINKER was approved for several accelerations and closed contracts with significant industries and institutes in Brazil and the world and had been achieving its goal of revolutionizing the way of making recombinant protein in the world.

BIOLINKER is a solutions company for the synthesis and purification of recombinant proteins. You design the protein and we produce it for you in a fast, practical, and high-quality way. We operate in the pharmaceutical, food, and academic markets.

Steve Scalia is the President of Tanner Pharma Group, a 20-year-old specialist pharmaceutical services provider headquartered in Charlotte, NC USA with offices in the United Kingdom, Brazil, Switzerland, and Ireland. Tanner provides a portfolio of service offerings focused on improving global access to medicines worldwide. In his role, Steve leads the company’s business activities with oversight of the commercial divisions, cross-functional departments, the Corporate Governance Team, and the Senior Management Team. Prior to joining Tanner Pharma in 2011, Steve founded three start-ups that included complex operating models and custom facilities requiring real estate development. Steve began his career in the pharmaceutical industry, holding sales and management positions at Upjohn Pharmaceuticals and Pharmacia Corp.

Jacobo Luchtan is the CEO and Co-Founder at HelloDoctor, a Mexican startup providing data-driven telehealth services. They operate in more than 10 Latin American countries and have successful cases with patients from each. They created a neutral bridge that connects patients and healthcare practitioners where they can provide online consultations, digital recipes, online pharmacies, track their medical records, and more. 
Jaco strongly believes that healthcare is a human right and anyone should have access to it, they developed a free online consultation service, where in 30 seconds you can speak to a practitioner from 5 different specialties. He is an industrial engineer, and technology fanatic and has been an entrepreneur all his life. Jaco implements innovative thoughts and technologies in order to create an incredible customer experience.

BS in Civil Engineering. More than 40 years of urban building experience; more than 20 years of experience in design-build; construction of pharmaceutical facilities, and more than 15 years involved in startups dealing with technological innovation.  

Founded Naveta Construcciones in 1983, a real estate development firm that completed more than 300 projects. Founded Grupo Inmobiliario Pharma, S.A. de C.V. (Parque Pharma®) back in 2003 as a boutique real estate firm focused on the Life Sciences Industry in Mexico. Back in  2009, founded Biohominis and Biodetecta, both biotech companies pursuing the molecular diagnostic market. In 2011, founded T4Oligo, a company focused on offering oligonucleotides to the Mexican market.

CEO and founder of the Alium group of companies in Peru. Rolando is a dentist, a service provider for the local dentistry sector, and a medical device distributor of dental products. Rolando’s academic credentials include a global executive MBA from the IESE business school, a fellowship in endodontics, and a degree in dental surgery.